It supports collagen production, which keeps skin supple and hair strong
Petersen J, Ludwig MQ, Juozaityte V, Ranea-Robles P, Svendsen C, Hwang E et al (2024) GLP-1-directed NMDA receptor antagonism for obesity treatment
The boxed-warning row is the one most often misread
It says gastrointestinal side effects are primarily driven by the GLP-1 component and that the DPP-4 inhibitor does not increase nausea
Beyond weight management, Semaglutide also targets type 2 diabetes, offering a comprehensive solution for improved health outcomes
When evaluating a specialist, consider the following: Credentials and training: Look for providers who are board-certified and experienced in obesity medicine or related fields